Weaver Consulting Group Johnson & Johnson Transaction History

Weaver Consulting Group

  • $264 Million
  • Q2 2024

A detailed history of Weaver Consulting Group transactions in Johnson & Johnson stock. As of the latest transaction made, Weaver Consulting Group holds 5,555 shares of JNJ stock, worth $919,463. This represents 0.31% of its overall portfolio holdings.

Number of Shares
5,555
Previous 5,527 0.51%
Holding current value
$919,463
Previous $874,000 7.21%
% of portfolio
0.31%
Previous 0.35%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
BUY
$144.38 - $157.78 $4,042 - $4,417
28 Added 0.51%
5,555 $811,000
Q1 2024

Apr 16, 2024
SELL
$155.22 - $162.74 $2,483 - $2,603
-16 Reduced 0.29%
5,527 $874,000
Q4 2023

Jan 22, 2024
BUY
$145.6 - $158.88 $5,678 - $6,196
39 Added 0.71%
5,543 $868,000
Q3 2023

Oct 13, 2023
SELL
$155.75 - $174.48 $6,697 - $7,502
-43 Reduced 0.78%
5,504 $857,000
Q2 2023

Jul 19, 2023
BUY
$154.35 - $166.11 $1,389 - $1,494
9 Added 0.16%
5,547 $918,000
Q1 2023

Apr 11, 2023
BUY
$151.05 - $180.26 $67,368 - $80,395
446 Added 8.76%
5,538 $858,000
Q4 2022

Jan 09, 2023
SELL
$160.2 - $179.79 $86,347 - $96,906
-539 Reduced 9.57%
5,092 $0
Q3 2022

Oct 04, 2022
SELL
$161.33 - $179.52 $35,815 - $39,853
-222 Reduced 3.79%
5,631 $920,000
Q2 2022

Jul 20, 2022
BUY
$168.19 - $186.01 $17,659 - $19,531
105 Added 1.83%
5,853 $1.04 Million
Q1 2022

May 06, 2022
SELL
$158.14 - $179.59 $32,576 - $36,995
-206 Reduced 3.46%
5,748 $1.02 Million
Q4 2021

Feb 01, 2022
SELL
$155.93 - $173.01 $9,511 - $10,553
-61 Reduced 1.01%
5,954 $1.02 Million
Q3 2021

Oct 28, 2021
SELL
$161.5 - $179.47 $79,458 - $88,299
-492 Reduced 7.56%
6,015 $971,000
Q2 2021

Jul 06, 2021
SELL
$159.48 - $171.07 $49,598 - $53,202
-311 Reduced 4.56%
6,507 $1.07 Million
Q1 2021

Apr 07, 2021
BUY
$153.07 - $170.48 $89,239 - $99,389
583 Added 9.35%
6,818 $1.12 Million
Q4 2020

Jan 29, 2021
BUY
$137.11 - $157.38 $61,562 - $70,663
449 Added 7.76%
6,235 $981,000
Q3 2020

Oct 28, 2020
SELL
$140.38 - $153.83 $2,386 - $2,615
-17 Reduced 0.29%
5,786 $861,000
Q2 2020

Jul 24, 2020
BUY
$128.81 - $155.51 $55,388 - $66,869
430 Added 8.0%
5,803 $816,000
Q1 2020

Apr 28, 2020
SELL
$111.14 - $153.99 $21,227 - $29,412
-191 Reduced 3.43%
5,373 $705,000
Q4 2019

Jan 31, 2020
BUY
$127.5 - $146.44 $29,580 - $33,974
232 Added 4.35%
5,564 $720,000
Q3 2019

Nov 22, 2019
BUY
$126.95 - $142.14 $253 - $284
2 Added 0.04%
5,332 $704,000
Q1 2019

Jun 19, 2019
BUY
$125.72 - $139.79 $670,087 - $745,080
5,330 New
5,330 $741,000

Others Institutions Holding JNJ

# of Institutions
4,160
Shares Held
1.69B
Call Options Held
12.5M
Put Options Held
10.3M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $433B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Weaver Consulting Group Portfolio

Follow Weaver Consulting Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email